Cargando…

Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults

BACKGROUND: Several scales to quantify the impact of potentially harmful medications (PHMs) have been shown to predict mortality and functional decline; however, the effect of PHMs on quality of life (QoL) has not been well-studied. OBJECTIVE: The aims of this study were to investigate an associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ie, Kenya, Chou, Eric, Boyce, Richard D., Albert, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684052/
https://www.ncbi.nlm.nih.gov/pubmed/29119486
http://dx.doi.org/10.1007/s40801-017-0123-8
_version_ 1783278395650473984
author Ie, Kenya
Chou, Eric
Boyce, Richard D.
Albert, Steven M.
author_facet Ie, Kenya
Chou, Eric
Boyce, Richard D.
Albert, Steven M.
author_sort Ie, Kenya
collection PubMed
description BACKGROUND: Several scales to quantify the impact of potentially harmful medications (PHMs) have been shown to predict mortality and functional decline; however, the effect of PHMs on quality of life (QoL) has not been well-studied. OBJECTIVE: The aims of this study were to investigate an association between PHM use and change in health-related QoL among community-dwelling older adults, and to compare the predictive capacity of PHM scales. METHODS: We conducted a retrospective cohort study using prescription claims data and survey responses. A total of 426 community-dwelling adults aged 65 years or older who visited senior centers and had received prescriptions through a statewide prescription drug subsidy program were included. Anticholinergic Cognitive Burden (ACB), Drug Burden Index-sedative component (DBI-Se), Drug Burden Index-anticholinergic component (DBI-ACh), and the number of regular medications and Beers list medications were calculated from the claims data between baseline and 12 months. In addition, change in the EuroQoL five-dimensions questionnaire (EQ-5D) between baseline and 6- and 12-month follow-up were measured as the main outcome. A linear mixed model was used for the analysis. RESULTS: After adjusting for covariates, both DBI-Se (coefficients − 0.076, 95% confidence interval [CI] − 0.131 to − 0.020) and DBI-Ach (coefficients − 0.095, 95% CI − 0.188 to − 0.002) significantly predicted a decline in EQ-5D index. The ACB, number of regular medications, and number of Beers medications did not have a significant association with EQ-5D changes. CONCLUSIONS: PHM measures incorporating dose revealed a better predictive capacity for QoL change. Reducing cumulative drug dose, as well as stopping medications, would be important for the well-being of this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40801-017-0123-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5684052
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-56840522017-11-27 Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults Ie, Kenya Chou, Eric Boyce, Richard D. Albert, Steven M. Drugs Real World Outcomes Original Research Article BACKGROUND: Several scales to quantify the impact of potentially harmful medications (PHMs) have been shown to predict mortality and functional decline; however, the effect of PHMs on quality of life (QoL) has not been well-studied. OBJECTIVE: The aims of this study were to investigate an association between PHM use and change in health-related QoL among community-dwelling older adults, and to compare the predictive capacity of PHM scales. METHODS: We conducted a retrospective cohort study using prescription claims data and survey responses. A total of 426 community-dwelling adults aged 65 years or older who visited senior centers and had received prescriptions through a statewide prescription drug subsidy program were included. Anticholinergic Cognitive Burden (ACB), Drug Burden Index-sedative component (DBI-Se), Drug Burden Index-anticholinergic component (DBI-ACh), and the number of regular medications and Beers list medications were calculated from the claims data between baseline and 12 months. In addition, change in the EuroQoL five-dimensions questionnaire (EQ-5D) between baseline and 6- and 12-month follow-up were measured as the main outcome. A linear mixed model was used for the analysis. RESULTS: After adjusting for covariates, both DBI-Se (coefficients − 0.076, 95% confidence interval [CI] − 0.131 to − 0.020) and DBI-Ach (coefficients − 0.095, 95% CI − 0.188 to − 0.002) significantly predicted a decline in EQ-5D index. The ACB, number of regular medications, and number of Beers medications did not have a significant association with EQ-5D changes. CONCLUSIONS: PHM measures incorporating dose revealed a better predictive capacity for QoL change. Reducing cumulative drug dose, as well as stopping medications, would be important for the well-being of this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40801-017-0123-8) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-11-08 /pmc/articles/PMC5684052/ /pubmed/29119486 http://dx.doi.org/10.1007/s40801-017-0123-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
Ie, Kenya
Chou, Eric
Boyce, Richard D.
Albert, Steven M.
Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults
title Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults
title_full Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults
title_fullStr Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults
title_full_unstemmed Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults
title_short Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults
title_sort potentially harmful medication use and decline in health-related quality of life among community-dwelling older adults
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684052/
https://www.ncbi.nlm.nih.gov/pubmed/29119486
http://dx.doi.org/10.1007/s40801-017-0123-8
work_keys_str_mv AT iekenya potentiallyharmfulmedicationuseanddeclineinhealthrelatedqualityoflifeamongcommunitydwellingolderadults
AT choueric potentiallyharmfulmedicationuseanddeclineinhealthrelatedqualityoflifeamongcommunitydwellingolderadults
AT boycerichardd potentiallyharmfulmedicationuseanddeclineinhealthrelatedqualityoflifeamongcommunitydwellingolderadults
AT albertstevenm potentiallyharmfulmedicationuseanddeclineinhealthrelatedqualityoflifeamongcommunitydwellingolderadults